Driving behaviour change for positive patient outcomes in pharma
September 25, 2024 | Behaviour change, Digital design, Digital pharma, Pharma, digital design agency, healthcare, healthcare digital design, healthcare digital design agency, patient engagement, pharma digital design, pharma digital design agency
Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.
In the world of healthcare, patient behaviour plays a crucial role in determining treatment outcomes and overall well-being. As pharmaceutical companies aim to improve patient adherence and outcomes, they have a unique opportunity to positively impact patient behaviour change.
In this article, we explore key approaches that can be adopted to foster positive patient behaviour change.
By understanding the factors that influence patient behaviour and employing effective strategies, pharmaceutical companies can empower patients to make informed decisions and actively participate in their own healthcare journey.
Education and awareness
One of the primary ways to influence patient behaviour is through education and awareness initiatives. By providing clear and concise information about medical conditions, treatment options, and potential benefits, providers can empower patients to make informed decisions.
This can be achieved through various channels, including online resources, educational materials, and partnerships with healthcare providers. Additionally, pharmaceutical companies can invest in public health campaigns to raise awareness about specific conditions and the importance of adhering to prescribed treatments.
In one of our projects, we collaborated with a pharma client to conduct a diary study for young people living with haemophilia. The long gaps between appointments with HCPs meant that the picture provided in consultations didn’t always accurately reflect patients’ health across the previous 6-12 months. The digital diary tool allowed patients to record their symptoms over time as they occurred, facilitating better quality conversations with HCPs and more tailored treatment recommendations. This is an example of how behaviour and habit change on the part of patients — in the form of answering regular questions about their health to form an ongoing diary — can enable better health outcomes.
Patient-centric communication
Effective communication is key to fostering positive patient behaviour change. Our user research with patients on behalf of our pharmaceutical clients has shown how they can facilitate patient-centric communication by using plain language and avoiding jargon that may confuse or overwhelm patients.
Clear instructions, dosage reminders, and information about potential side effects will also all contribute to patient understanding and compliance. Utilising digital platforms, such as mobile apps or patient portals, can further enhance communication by providing personalised support and content, and real-time feedback.
Supportive resources and tools
Pharma organisations can provide supportive resources and tools to help patients overcome barriers and facilitate behaviour change. This could include smartphone applications that track medication adherence, reminder systems, or interactive platforms that provide tailored treatment plans and lifestyle recommendations.
When creating effective digital support tools and content, accessibility and ease of use is key. With effective UX and UI design, patients will be able to intuitively navigate and interact with your tools to truly benefit from the services on offer. Additionally, partnering with patient advocacy groups to develop online communities can provide a valuable network of support, allowing patients to connect with others facing similar challenges and share experiences.
Learnings from behavioural science
Incorporating insights from behavioural science and research can significantly impact patient behaviour change. Techniques such as goal-setting and positive reinforcement can motivate patients and encourage sustained engagement. Pharma teams can often leverage existing technology to create interactive apps or online platforms that reward patients for achieving treatment milestones or adhering to prescribed regimens.
First-hand user research insights
When seeking to understand what will motivate patients to positively change their behaviour, there’s no replacement for speaking to them first-hand.
Conducting patient research, interviews and usability testing is a great way to understand what patients really want and need from their care offerings. In one recent project, we partnered with a specialist biopharma organisation to conduct user interviews with patients living with an ultra-rare life-limiting condition. This in-depth insight about the daily lived experiences of patients has informed the design process for a new digital patient support tool.
By fully understanding their patients, companies can ensure the products or programs they develop are always aligned to their needs.
Collaboration and partnerships
Collaboration between pharmaceutical companies, healthcare providers, and patient advocacy groups is essential in driving positive behaviour change. By working together, stakeholders can align their efforts to provide comprehensive care and support for patients.
Pharma organisations can partner with healthcare providers to develop educational programs, conduct joint research, and ensure consistent messaging. Collaborating with patient advocacy groups allows for a deeper understanding of patient needs, preferences, and challenges, resulting in more tailored interventions that promote positive behaviour change.
Supporting patients to take control of their own health
When it comes to living with a disease or other health condition, knowledge is power. The strategies outlined above aim to allow patients to better understand their own condition, so they can make more informed decisions and change their behaviours in a way that will positively impact their lives and health.
By teaching patients and their caregivers to recognise their symptoms and join the dots between health-related events, we can help alleviate anxiety and uncertainty and empower patients with more in-depth knowledge.
Final thoughts
Pharmaceutical companies have a unique opportunity to positively impact patient behaviour change by implementing various strategies. Through education, patient-centric communication, well-designed support tools, behavioural research and insight, and collaboration, organisations can empower patients to take an active role in their healthcare journey.
By fostering positive behaviour change, pharma and other providers can contribute to improved patient outcomes, better treatment adherence, and ultimately, a healthier society.
If you’re looking for an experienced digital design and research partner to support you in creating patient-facing digital products and services that drive behaviour change and impact, get in touch.
This content was provided by Graphite Digital
Company Details
Latest Content from Graphite Digital
How user research will help you create better digital products, whatever stage you’re at
User research provides valuable insight that will help you create better digital products and services, whatever stage you’re at.
Advancing digital engagement in pharma and healthcare: 2024 focus areas
6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users
Building trust with HCPs: 6 takeaways from our industry webinar
Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
What are design systems and how can they help you elevate your digital products?
Design Systems aren’t new, but the potential to utilise them to improve the way in which teams produce digital products is still untapped for many in the pharmaceutical and healthcare...
The impact of mindset on digital product success: Download our new whitepaper
Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...
Demonstrating the value of UX research in pharma and healthcare
Demonstrating the value of UX research in pharma and healthcare can be difficult. Here, Graphite's Senior Clinical UX Researcher, Jack Burton, explains the importance of user research within the digital...
Overcoming challenges in digital pharma to get to launch quicker
We take a look at why it can take pharma businesses so long to get their digital products into the hands of patients or HCPs, and what can be done...
The Contradiction Conundrum: New digital pharma report
New research, based on the views of 450 pharma professionals, reveals contradictions in how pharma organisations are approaching their digital products and strategies.
- 1
- 2